Suzhou Basecare Medical Corporation Limited (Basecare Medical) obtained decisive shareholder support for every item on the agenda at its 2025 Annual General Meeting held on 4 June 2026 in Suzhou, Jiangsu Province. All eight ordinary resolutions and three special resolutions were approved by poll.

Attendance and Voting Strength • Shareholders or proxies representing 195.93 million shares—equivalent to 71.63 % of the company’s 273.53 million issued shares—participated in the meeting.

Ordinary Resolutions (Simple-majority required) • Board report, board of supervisors report, 2025 annual report, and 2025 profit distribution plan each received 99.30 % support. • 2025 financial accounts and 2026 financial budget, as well as the remuneration plan for directors, were endorsed with 91.55 % approval. • Re-appointment of KPMG as external auditor for 2026 was ratified with 99.30 % support, authorising the Board to determine remuneration and related matters.

Special Resolutions (Two-thirds majority required) • General mandate to issue additional shares secured 98.17 % approval. • General mandate to repurchase H-shares passed with 91.55 % support. • Proposed amendments to the articles of association attracted 99.30 % in favour.

Corporate Governance Notes • All eight directors attended the AGM. • No shareholders were required to abstain under Hong Kong Listing Rules, and no treasury shares were outstanding. • Computershare Hong Kong Investor Services Limited acted as scrutineer for vote-taking.

The voting outcomes affirm broad shareholder confidence in Basecare Medical’s strategic direction, financial stewardship, and governance framework as the company enters its 2026 financial year.